International Clinical Trial: Establish a detection protocol for peripheral blood MDSC and study its clinical value in the diagnosis and treatment of solid tumors

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114749) titled 'Establish a detection protocol for peripheral blood MDSC and study its clinical value in the diagnosis and treatment of solid tumors' on Dec. 17, 2025.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Cancer Hospital Chinese Academy of Medical Sciences

Condition: Solid tumor

Intervention: Good prognosis:N/A Poor prognosis:N/A

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2024-11-10

Target Sample Size: Good prognosis:150;Poor prognosis:150;Healthy control group:150;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/...